West Pharmaceutical Services has announced receipt of the Food and Drug Administration (FDA) 510(k) clearance and the launch of its Vial2Bag Advanced 20mm Admixture Device.
The new device is designed to enable the reconstitution and transfer of a drug between a vial and an IV bag.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIt features both a dual-channel design to offer dedicated fluid pathways into and out of the IV bag. Additionally, it has a vial spike design, which enhances the connection to the drug vial.
Furthermore, the new admixture device is needle-free, in accordance with OSHA and NAPPSI sharps prevention guidance.
The device is also a simple solution for just-in-time IV medication preparation, enhancing the efficiency of point-of-care nursing.
It also helps to reduce drug and IV fluid waste by offering universal compatibility with all manufacturers’ IV bags up to 250ml. It is also suitable for use with liquid and powder medications with standard 20mm closure vials.
West Commercial Products and Solutions senior vice-president Cindy Reiss-Clark said: “The development of our Vial2Bag Advanced device is a true example of our ongoing commitment to product development and point-of-care delivery.
“This solution is needed now more than ever in the current healthcare climate, and West is pleased to bring this innovation to the market.”
West Pharmaceutical Service specialises in the manufacturing of packaging components and delivery systems for injectable drugs and healthcare products.
The company said it recorded net sales worth $1.84bn last year.
